3-(3-chlorophenyl)-8-methyl-2H-[1,3,5]triazino[2,1-b][1,3]benzothiazole-2,4(3H)-dione

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 英文名称: 3-(3-chlorophenyl)-8-methyl-2H-[1,3,5]triazino[2,1-b][1,3]benzothiazole-2,4(3H)-dione
• 英文别名: 3-(3-chlorophenyl)-8-methyl-[1,3,5]triazino[2,1-b][1,3]benzothiazole-2,4-dione
• 化学式: C₁₆H₁₀ClN₃O₂S
• mdl: MFCD03488038
• 分子量: 343.8
• InChiKey: TWFOMURCRPDYHN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  23
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  78.3
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• [EN] INHIBITORS OF PHOSPHODIESTERASES 11 (PDE11) AND METHODS OF USE TO ELEVATE CORTISOL PRODUCTION<br/>[FR] INHIBITEURS DE PHOSPHODIESTÉRASES 11 (PDE11) ET PROCÉDÉS D'UTILISATION POUR AUGMENTER LA PRODUCTION DE CORTISOL
  申请人：TRUSTEES BOSTON COLLEGE

  公开号：WO2013082275A1

  公开（公告）日：2013-06-06

  The present intervention generally relates to compositions comprising a PDE11 inhibitor for increasing cortisol levels in a subject, or for increasing the production of cortisol from adenocortical cells in a subject. Aspects of the invention relate to the use of a PDE11 inhibitor in a method of treatment of low cortisol levels and/or adrenal insufficiency in a subject, or a method of treating a disease or disorders associated with adrenal insufficiency. Aspects of the invention relate to PDE11 inhibitors belonging to compounds of formula (I)-(VI), and their use alone or in combination with long-term corticosteroid treatment to elevate cortisol levels in a subject, and/or to treat adrenal insufficiency. Another aspect relates to kits comprising PDE11 inhibitors for administration to a subject, pharmaceutical compositions comprising compounds of formula (I)-(VI) for use in methods to increase cortisol levels and/or treat adrenal insufficiency, and their use as an adjuvant for treatment of cancer or other disorders such as psychiatric diseases where elevating cortisol levels would be beneficial to the subject.